/

Pfizer Inc.

PFE US

PFE USPfizer Inc.

United States Composite

26.00

USD

+0.61

(+2.40%)

0.37EPS Dil.

69.24P/E

146.80BMarket Cap

6.30%Div. Yield

Next Earnings

May 1

Ex-Dividend Date

January 25

Dividend Date

March 1

Held by Insiders

0.05%

Held by Institutions

69.96%

Short % of Float

1.17%

YTD Yield

-31.69%

3Y Yield

-30.26%

5Y Yield

-27.04%

Capital Structure

FRC

•

in mil. unless spec.

Jun'23

Sep'23

Dec'23

ST Debt

3,985

2,548

10,346

LT Borrowings

61,356

61,048

60,499

LT Finance Leases

- -

Preferred Equity and Hybrid Capital

- -

Shares Outstanding

5,645

5,646

Market Capitalization

207,059

187,278

162,548

Working Capital

FRC

•

in mil. unless spec.

Jun'23

Sep'23

Dec'23

Total Current Assets

73,347

74,012

43,333

Cash, Cash Equivalents & STI

44,785

44,181

12,690

Accounts Receivable, Net

10,231

11,086

11,177

Inventories

10,310

10,204

10,189

Total Current Liabilities

34,647

31,136

47,794

Payables & Accruals

11,324

7,236

11,431

ST Debt

3,985

2,548

10,346

Deferred Revenue

1,286

2,204

2,700

Growth Rates

FRC

•

in mil. unless spec.

(avg. rate of change)

10 years

5 years

1 year

Sales/Revenue/Turnover

5.89%

15.78%

-41.70%

Net Income, GAAP

15.93%

18.06%

-93.25%

Free Cash Flow

3.60%

10.22%

-81.59%

Total Cash Common Dividend

3.48%

3.01%

2.94%

Total Equity

2.35%

7.70%

-6.91%

Quarterly Revenue

FRC

•

in mil. unless spec.

Year

2021

14,516

18,899

24,035

23,635

81,288

2022

25,661

27,742

22,638

24,290

100,330

2023

18,282

12,734

13,232

14,249

58,496

Quarterly Earnings Per Share

FRC

•

in mil. unless spec.

Year

2021

0.87

0.99

1.45

0.60

3.92

2022

1.40

1.77

1.54

0.89

5.59

2023

0.98

0.41

-0.42

-0.60

0.38

Quarterly Dividends Per Share

FRC

•

in mil. unless spec.

Year

2021

0.39

1.56

2022

0.40

1.60

2023

0.41

1.64

Company Description

CEO: Dr. Albert Bourla D.V.M., Ph.D.
Full Time Employees: 88,000
Sector: Healthcare
Industry: Drug Manufacturers - General
Address: 66 Hudson Boulevard East New York NY United States 10001-2192
IPO Date: Jun 1, 1972
CIK: 0000078003
Website: www.pfizer.com
Business: Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the United States, Europe, and internationally. The company offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic, migraine, and women's health under the Eliquis, Nurtec ODT/Vydura, Zavzpret, and the Premarin family brands; infectious diseases with unmet medical needs under the Prevnar family, Abrysvo, Nimenrix, FSME/IMMUN-TicoVac, and Trumenba brands; and COVID-19 prevention and treatment, and potential future mRNA and antiviral products under the Comirnaty and Paxlovid brands. It also provides medicines and vaccines in various therapeutic areas, such as biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Litfulo, Velsipity, and Cibinqo brands; amyloidosis, hemophilia, endocrine diseases, and sickle cell disease under the Vyndaqel family, Oxbryta, BeneFIX, Somavert, Ngenla, and Genotropin brands; sterile injectable and anti-infective medicines under the Sulperazon, Medrol, Zavicefta, Zithromax, and Panzyga brands; and biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Inlyta, Bosulif, Mektovi, Padcev, Adcetris, Talzenna, Tukysa, Elrexfio, Tivdak, Lorbrena, and Braftovi brands. In addition, the company involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, individual provider offices, retail pharmacies, and integrated delivery systems. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Merck KGaA; and BioNTech SE. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.

Company News

Zacks
17 days ago
These 2 Medical Stocks Could Beat Earnings: Why They Should Be on Your Radar
Reuters
18 days ago
US takes next step in Medicare drug price negotiations with pharma companies
Yahoo
18 days ago
Why Investors Need to Take Advantage of These 2 Medical Stocks Now
Zacks
18 days ago
Why Investors Need to Take Advantage of These 2 Medical Stocks Now
Reuters
18 days ago
Roivant's anti-inflammatory drug succeeds in mid-stage study
FOOL
18 days ago
3 Magnificent Ultra-High-Yield Dividend Stocks That Are Screamings Buys in April
Zacks
18 days ago
Pfizer (PFE) Stock Moves -0.11%: What You Should Know
Yahoo
18 days ago
Pfizer (PFE) Stock Moves -0.11%: What You Should Know
Reuters
18 days ago
Column: Conservative groups object to 'naming names' rule from Pfizer diversity decision
Yahoo
19 days ago
Bristol Myers' (BMY) Zeposia Fails Crohn's Disease Study
Zacks
19 days ago
Bristol Myers' (BMY) Zeposia Fails Crohn's Disease Study
FOOL
19 days ago
2 Stocks Down 30% and 27% to Buy and Hold
CNN
19 days ago
US scientists are leaving academia. That’s bad news for drug companies
Biopharmadive
19 days ago
5 FDA decisions to watch in the second quarter
FOOL
19 days ago
Better Recovery Story Buy: Pfizer vs Moderna
CNBC
22 days ago
Cramer's Lightning Round: Leidos is a winner
Reuters
22 days ago
US CDC alerts healthcare providers of increase in meningococcal disease
Yahoo
23 days ago
20 Best Stocks to Buy Right Now According to Financial Media
Yahoo
24 days ago
Moderna (MRNA) Posts Upbeat Data From Next-Gen COVID Jab Study
Zacks
24 days ago
Moderna (MRNA) Posts Upbeat Data From Next-Gen COVID Jab Study

Company Description

CEO: Dr. Albert Bourla D.V.M., Ph.D.
Full Time Employees: 88,000
Sector: Healthcare
Industry: Drug Manufacturers - General
Address: 66 Hudson Boulevard East New York NY United States 10001-2192
IPO Date: Jun 1, 1972
CIK: 0000078003
Website: www.pfizer.com
Business: Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the United States, Europe, and internationally. The company offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic, migraine, and women's health under the Eliquis, Nurtec ODT/Vydura, Zavzpret, and the Premarin family brands; infectious diseases with unmet medical needs under the Prevnar family, Abrysvo, Nimenrix, FSME/IMMUN-TicoVac, and Trumenba brands; and COVID-19 prevention and treatment, and potential future mRNA and antiviral products under the Comirnaty and Paxlovid brands. It also provides medicines and vaccines in various therapeutic areas, such as biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Litfulo, Velsipity, and Cibinqo brands; amyloidosis, hemophilia, endocrine diseases, and sickle cell disease under the Vyndaqel family, Oxbryta, BeneFIX, Somavert, Ngenla, and Genotropin brands; sterile injectable and anti-infective medicines under the Sulperazon, Medrol, Zavicefta, Zithromax, and Panzyga brands; and biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Inlyta, Bosulif, Mektovi, Padcev, Adcetris, Talzenna, Tukysa, Elrexfio, Tivdak, Lorbrena, and Braftovi brands. In addition, the company involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, individual provider offices, retail pharmacies, and integrated delivery systems. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Merck KGaA; and BioNTech SE. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.

Company News

Zacks
17 days ago
These 2 Medical Stocks Could Beat Earnings: Why They Should Be on Your Radar
Reuters
18 days ago
US takes next step in Medicare drug price negotiations with pharma companies
Yahoo
18 days ago
Why Investors Need to Take Advantage of These 2 Medical Stocks Now
Zacks
18 days ago
Why Investors Need to Take Advantage of These 2 Medical Stocks Now
Reuters
18 days ago
Roivant's anti-inflammatory drug succeeds in mid-stage study
FOOL
18 days ago
3 Magnificent Ultra-High-Yield Dividend Stocks That Are Screamings Buys in April
Zacks
18 days ago
Pfizer (PFE) Stock Moves -0.11%: What You Should Know
Yahoo
18 days ago
Pfizer (PFE) Stock Moves -0.11%: What You Should Know
Reuters
18 days ago
Column: Conservative groups object to 'naming names' rule from Pfizer diversity decision
Yahoo
19 days ago
Bristol Myers' (BMY) Zeposia Fails Crohn's Disease Study
Zacks
19 days ago
Bristol Myers' (BMY) Zeposia Fails Crohn's Disease Study
FOOL
19 days ago
2 Stocks Down 30% and 27% to Buy and Hold
CNN
19 days ago
US scientists are leaving academia. That’s bad news for drug companies
Biopharmadive
19 days ago
5 FDA decisions to watch in the second quarter
FOOL
19 days ago
Better Recovery Story Buy: Pfizer vs Moderna
CNBC
22 days ago
Cramer's Lightning Round: Leidos is a winner
Reuters
22 days ago
US CDC alerts healthcare providers of increase in meningococcal disease
Yahoo
23 days ago
20 Best Stocks to Buy Right Now According to Financial Media
Yahoo
24 days ago
Moderna (MRNA) Posts Upbeat Data From Next-Gen COVID Jab Study
Zacks
24 days ago
Moderna (MRNA) Posts Upbeat Data From Next-Gen COVID Jab Study